Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Inv. presentation
Quarterly results
|
|
Ensysce Biosciences, Inc. (LACQ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| GOWER BOB G (Director) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Bought 90,287 shares
@ $0.4883, valued at
$44.1k
|
|
| 03/02/2023 |
4
| GOWER BOB G (Director) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Bought 109,300 shares
@ $0.4883, valued at
$53.4k
Bought 270,000 shares
@ $0.4777, valued at
$129k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Rosebraugh Curtis (Director) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.425, valued at
$8.5k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Levin Adam (Director) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.425, valued at
$6.4k
|
|
| 05/27/2022 |
4
| Kirkpatrick Lynn (CEO) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Bought 70,000 shares
@ $0.4869, valued at
$34.1k
Bought 27,000 shares
@ $0.5265, valued at
$14.2k
Granted 200,000 options to buy
@ $1.4, valued at
$280k
|
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Birkett Kevin Geoffrey (Chief Commercial Officer) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.4, valued at
$70k
|
|
| 02/24/2022 |
4
| Kirkpatrick Lynn (CEO) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.4, valued at
$280k
|
|
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Humphrey David Carl (CFO) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 07/02/2021 |
4
| Chang William H (10% Owner) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 353,451 shares
@ $0
Granted 2,242,189 shares
@ $0 |
|
| 07/02/2021 |
4
| GOWER BOB G (10% Owner) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 7,919,026 shares
@ $0
Granted 6,585 options
@ $2.59, valued at
$17.1k
|
|
| 07/02/2021 |
4
| Kirkpatrick Lynn (CEO) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 284,851 shares
@ $0
Granted 99,950 options
@ $3.21, valued at
$320.8k
Granted 9,994 options
@ $3.21, valued at
$32.1k
Granted 263,400 options
@ $3.19, valued at
$840.2k
Granted 460,950 options
@ $1.83, valued at
$843.5k
Granted 817,560 options
@ $1.68, valued at
$1.4M
Granted 658,500 options
@ $2.59, valued at
$1.7M
Granted 6,585 options
@ $2.59, valued at
$17.1k
|
|
| 07/02/2021 |
4
| Benton Andrew (Director) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 65,850 options to buy
@ $3.35, valued at
$220.6k
|
|
| 07/02/2021 |
4
| Martin Steven Robert (Director) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 65,850 options to buy
@ $3.35, valued at
$220.6k
|
|
| 07/02/2021 |
4
| Wright Richard Chester (Chief Business Officer) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 49,975 options
@ $3.21, valued at
$160.4k
Granted 65,850 options
@ $1.83, valued at
$120.5k
Granted 263,400 options
@ $1.83, valued at
$482k
Granted 19,755 options
@ $2.59, valued at
$51.2k
Granted 987,750 options
@ $2.59, valued at
$2.6M
|
|
| 07/02/2021 |
4
| Schmidt William K (Chief Medical Officer) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 69,142 options
@ $3.22, valued at
$222.6k
|
|
| 07/02/2021 |
4
| Birkett Kevin Geoffrey (Chief Commercial Officer) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 19,755 options
@ $2.59, valued at
$51.2k
Granted 329,250 options
@ $2.59, valued at
$852.8k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2018 |
4
| HG Vora Capital Management, LLC (10% Owner) has filed a Form 4 on Leisure Acquisition Corp.|
Txns:
| Bought 1,000,000 shares
@ $10, valued at
$10M
Disposed of 375,000 shares
@ $0 |
|
| 01/17/2018 |
4
| WEIL A LORNE (Executive Chairman) has filed a Form 4 on Leisure Acquisition Corp.|
Txns:
| Disposed of 40,645 shares
@ $0
Disposed of 132,158 shares
@ $0 |
|
|
|
|